# Biomarkers of Irritant-Induced and Allergic Asthma

> **NCT02740543** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 18 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone propionate HFA 220

## Key facts

- **NCT ID:** NCT02740543
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2019-10-23
- **Final completion:** 2019-10-23
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740543, "Biomarkers of Irritant-Induced and Allergic Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02740543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*